CN104720919A - 瘤胃疾病治疗系统 - Google Patents
瘤胃疾病治疗系统 Download PDFInfo
- Publication number
- CN104720919A CN104720919A CN201510157178.1A CN201510157178A CN104720919A CN 104720919 A CN104720919 A CN 104720919A CN 201510157178 A CN201510157178 A CN 201510157178A CN 104720919 A CN104720919 A CN 104720919A
- Authority
- CN
- China
- Prior art keywords
- support column
- puncture
- protractor
- needle
- cud
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 34
- 201000010099 disease Diseases 0.000 title claims abstract description 32
- 210000004767 rumen Anatomy 0.000 title abstract description 33
- 241000282849 Ruminantia Species 0.000 claims abstract description 23
- 238000013022 venting Methods 0.000 claims description 71
- 238000002347 injection Methods 0.000 claims description 56
- 239000007924 injection Substances 0.000 claims description 56
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 claims description 42
- 239000007788 liquid Substances 0.000 claims description 17
- 241000283690 Bos taurus Species 0.000 claims description 16
- 238000003825 pressing Methods 0.000 claims description 9
- 238000010276 construction Methods 0.000 claims description 7
- 210000001015 abdomen Anatomy 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 210000004534 cecum Anatomy 0.000 claims description 3
- 230000000994 depressogenic effect Effects 0.000 claims description 3
- 230000002093 peripheral effect Effects 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 230000006835 compression Effects 0.000 claims 1
- 238000007906 compression Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 25
- 241001465754 Metazoa Species 0.000 abstract description 12
- 210000004913 chyme Anatomy 0.000 abstract description 8
- 230000000903 blocking effect Effects 0.000 abstract description 5
- 230000005284 excitation Effects 0.000 abstract description 5
- 239000012530 fluid Substances 0.000 abstract description 5
- 230000033764 rhythmic process Effects 0.000 abstract description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 3
- 206010000060 Abdominal distension Diseases 0.000 abstract 1
- 208000024330 bloating Diseases 0.000 abstract 1
- 239000006172 buffering agent Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 description 15
- 239000007789 gas Substances 0.000 description 12
- 201000006549 dyspepsia Diseases 0.000 description 10
- 230000002496 gastric effect Effects 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 238000003780 insertion Methods 0.000 description 9
- 230000037431 insertion Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 239000006260 foam Substances 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 238000001802 infusion Methods 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 230000010412 perfusion Effects 0.000 description 5
- 210000002460 smooth muscle Anatomy 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000003187 abdominal effect Effects 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 230000001537 neural effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- JBYXPOFIGCOSSB-UQGDGPGGSA-N rumenic acid Chemical compound CCCCCC\C=C/C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-UQGDGPGGSA-N 0.000 description 4
- 208000005223 Alkalosis Diseases 0.000 description 3
- 230000002340 alkalosis Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000002381 Brain Hypoxia Diseases 0.000 description 2
- 208000018672 Dilatation Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000002318 cardia Anatomy 0.000 description 2
- 239000002371 cardiac agent Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000028299 esophageal disease Diseases 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000000283 vasomotion Effects 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Natural products C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229940023964 caffeine and sodium benzoate Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- RBNPZEHAODHBPZ-UHFFFAOYSA-M dihydroxyaluminium Chemical compound O.O.NCC(=O)O[Al] RBNPZEHAODHBPZ-UHFFFAOYSA-M 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960002362 neostigmine Drugs 0.000 description 1
- LULNWZDBKTWDGK-UHFFFAOYSA-M neostigmine bromide Chemical compound [Br-].CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 LULNWZDBKTWDGK-UHFFFAOYSA-M 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- -1 progesterone compound Chemical class 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- JWBPVFVNISJVEM-UHFFFAOYSA-M sodium caffeine benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1.CN1C(=O)N(C)C(=O)C2=C1N=CN2C JWBPVFVNISJVEM-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000032895 transmembrane transport Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D1/00—Surgical instruments for veterinary use
- A61D1/14—Devices for degassing animals' stomachs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510157178.1A CN104720919B (zh) | 2015-04-06 | 2015-04-06 | 瘤胃疾病治疗系统 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510157178.1A CN104720919B (zh) | 2015-04-06 | 2015-04-06 | 瘤胃疾病治疗系统 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104720919A true CN104720919A (zh) | 2015-06-24 |
CN104720919B CN104720919B (zh) | 2016-09-14 |
Family
ID=53445737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510157178.1A Active CN104720919B (zh) | 2015-04-06 | 2015-04-06 | 瘤胃疾病治疗系统 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104720919B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105327443A (zh) * | 2015-11-20 | 2016-02-17 | 宋明全 | 一种消化内科用胃镜上药器 |
CN110772354A (zh) * | 2018-07-26 | 2020-02-11 | 柴印成 | 一种用于具有皮肤病的成年活猪护理用兽栏及使用方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1902418A (en) * | 1931-11-02 | 1933-03-21 | Jensen Salsbery Lab Inc | Surgical instrument |
US3039468A (en) * | 1959-01-07 | 1962-06-19 | Joseph L Price | Trocar and method of treating bloat |
US3127894A (en) * | 1960-09-26 | 1964-04-07 | Gail B Smith | Method of medicine administration and device therefor |
US4083370A (en) * | 1976-11-03 | 1978-04-11 | Taylor John D | Bloat relief tube and holder |
CN201283014Y (zh) * | 2008-11-06 | 2009-08-05 | 王弘学 | 反刍动物瘤胃臌气放气锥 |
CN203647527U (zh) * | 2013-12-16 | 2014-06-18 | 周庆民 | 一种奶牛瘤胃穿刺器 |
CN203898481U (zh) * | 2014-06-19 | 2014-10-29 | 四川农业大学 | 一种用于治疗反刍动物瘤胃臌气的多功能装置 |
-
2015
- 2015-04-06 CN CN201510157178.1A patent/CN104720919B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1902418A (en) * | 1931-11-02 | 1933-03-21 | Jensen Salsbery Lab Inc | Surgical instrument |
US3039468A (en) * | 1959-01-07 | 1962-06-19 | Joseph L Price | Trocar and method of treating bloat |
US3127894A (en) * | 1960-09-26 | 1964-04-07 | Gail B Smith | Method of medicine administration and device therefor |
US4083370A (en) * | 1976-11-03 | 1978-04-11 | Taylor John D | Bloat relief tube and holder |
CN201283014Y (zh) * | 2008-11-06 | 2009-08-05 | 王弘学 | 反刍动物瘤胃臌气放气锥 |
CN203647527U (zh) * | 2013-12-16 | 2014-06-18 | 周庆民 | 一种奶牛瘤胃穿刺器 |
CN203898481U (zh) * | 2014-06-19 | 2014-10-29 | 四川农业大学 | 一种用于治疗反刍动物瘤胃臌气的多功能装置 |
Non-Patent Citations (1)
Title |
---|
审军士: "瘤胃穿刺技术及其在奶牛亚急性瘤胃酸中毒诊断中的应用", 《动物生产》, vol. 49, no. 1, 10 January 2013 (2013-01-10) * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105327443A (zh) * | 2015-11-20 | 2016-02-17 | 宋明全 | 一种消化内科用胃镜上药器 |
CN105327443B (zh) * | 2015-11-20 | 2018-06-19 | 宋明全 | 一种消化内科用胃镜上药器 |
CN110772354A (zh) * | 2018-07-26 | 2020-02-11 | 柴印成 | 一种用于具有皮肤病的成年活猪护理用兽栏及使用方法 |
CN110772354B (zh) * | 2018-07-26 | 2021-07-16 | 胡彦平 | 一种用于具有皮肤病的成年活猪护理用兽栏及使用方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104720919B (zh) | 2016-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104739538B (zh) | 一种治疗瘤胃臌气的快速放气消导装置 | |
CN104720919B (zh) | 瘤胃疾病治疗系统 | |
CN104720920B (zh) | 瘤胃疾病治疗装置 | |
CN104586529B (zh) | 用于反刍动物瘤胃臌气的综合治疗系统 | |
CN104720925B (zh) | 反刍动物瘤胃疾病综合治疗系统 | |
CN104720918B (zh) | 反刍动物瘤胃疾病治疗装置 | |
CN104546205B (zh) | 瘤胃臌气穿刺针 | |
CN104622596B (zh) | 泡沫性瘤胃臌气放气穿刺装置 | |
CN104546206B (zh) | 一种治疗瘤胃臌气的穿刺放气针 | |
CN104546208B (zh) | 一种治疗反刍动物瘤胃臌气的装置 | |
CN104720921B (zh) | 具有按摩功能的瘤胃疾病治疗装置 | |
CN104622597B (zh) | 反刍动物瘤胃臌气穿刺针 | |
CN104586526B (zh) | 一种治疗瘤胃臌气的穿刺放气装置 | |
CN104605957B (zh) | 瘤胃臌气穿刺放气装置 | |
CN104546207B (zh) | 瘤胃臌气综合治疗装置 | |
CN104758078B (zh) | 急性瘤胃臌气快速治疗装置 | |
CN104586528B (zh) | 泡沫性瘤胃臌气放气穿刺针 | |
CN104586527B (zh) | 反刍动物瘤胃臌气穿刺放气装置 | |
CN104758077B (zh) | 具有按摩功能的瘤胃疾病治疗系统 | |
CN207666963U (zh) | 一种术后麻醉用置留管 | |
US20160051582A1 (en) | Pharmaceutical composition for treatment of chronic pain | |
Williams et al. | The mode of action of morphine upon the intestine | |
CN109893283B (zh) | 一种瘤胃疾病治疗器 | |
CN109893284B (zh) | 瘤胃疾病治疗器 | |
CN213131510U (zh) | 一种多腔胃管 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Zengyuan Inventor before: Zhang Yi Inventor before: Liu Honggeng Inventor before: Wang Hanyue |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170920 Address after: 300000 Tianjin city Jinnan District king Lotus Road North Yincui Mingyuan building 36 -1-1403 Patentee after: Wang Zengyuan Address before: 315040 Zhejiang province Ningbo City Jiangdong District Zhaohui road 389 Lane No. 9 room 304 Co-patentee before: Zhang Yi Patentee before: Wang Qiaoqiao Co-patentee before: Liu Honggeng Co-patentee before: Wang Hanyue |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180607 Address after: 226000 No. 998 Century Avenue, Nantong high tech Zone, Jiangsu Patentee after: NANTONG XIANGJING BIOMEDICINE TECHNOLOGY CO.,LTD. Address before: 300000 -1-1403, 36 building, Ying Tsui court, north of Jing Lian Road, Jinnan District, Tianjin. Patentee before: Wang Zengyuan |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Rumen disease treatment system Effective date of registration: 20210719 Granted publication date: 20160914 Pledgee: China Construction Bank Corporation Nantong TongZhou sub branch Pledgor: NANTONG XIANGJING BIOMEDICINE TECHNOLOGY Co.,Ltd. Registration number: Y2021980006341 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230807 Granted publication date: 20160914 Pledgee: China Construction Bank Corporation Nantong TongZhou sub branch Pledgor: NANTONG XIANGJING BIOMEDICINE TECHNOLOGY CO.,LTD. Registration number: Y2021980006341 |